Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils

Journal of Clinical Investigation

Volumn 102, Issue 4, 1998, Pages 663-670

  Coffey, Michael J ^a,b   Phare, Susan M ^a   George, Sarah ^a   Peters Golden, Marc ^a   Kazanjian, Powel H ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

AIDS; Cytokines; Eicosanoids; Opportunistic infections; Prostaglandins

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; LEUKOTRIENE;

ANTIFUNGAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYPTOCOCCOSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE ACTIVATION; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032528887     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2117     Document Type: Article

References (40)

1. Centers for Disease Control. 1986. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Ann. Intern. Med. 105:234-237.
2. Roilides, E., S. Mertins, J. Eddy, T.J. Walsh, P.A. Pizzo, and M. Rubin. 1990. Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor. J. Pediatr. 117:531-540.
3. Roilides, E., T. Walsh, P. Pizzo, and M. Rubin. 1991. Granulocyte colony stimulation factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J. Infect. Dis. 163:574-583.
4. Pitrak, D., P. Bak, P. De Marais, R. Novak, and B. Andersen. 1993. Depressed neutrophil superoxide production in human immunodeficiency virus infection. J. Infect. Dis. 167:1406-1410.
5. Cher, T., R. Roberts, W. Kg. B. Ank, and E. Stiehm. 1993. Decreased superoxide anion and hydrogen peroxide production by neutrophils and monocytes in HIV-infected children and adults. Pediatr. Res. 34:544-550.
6. Hirschtick, R., J. Glassroth, M. Jordan, T. Wilcosky, J. Wallace, P. Kvale, N. Markowitz, M. Rosen, B. Mangura, P. Hopewell, et al. 1995. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N. Engl. J. Med. 333:845-851.
7. Needleman, P., J. Turk, B.A. Jakschik, A.R. Morrison, and J.B. Lefkowith. 1986. Arachidonic acid metabolism. Annu. Rev. Biochem. 55:69-102.
8. 4. J. Biol. Chem. 264:19469-19472.
9. Henderson, W., Jr. 1987. Eicosanoids and lung inflammation. Am. Rev. Respir. Dis. 135:1176-1185.
10. Serhan, C., U. Lundberg, G. Weissmann, and B. Samuelsson. 1984. Formation of leukotrienes and hydroxy acids from human neutrophils and platelets exposed to monosodium urate. Prostaglandins. 27:563-581.
11. 4. Int. J. Immunopharmacol. 11:801-808.
12. 4 receptor antagonist. Biochem. Pharmacol. 49:1683-1690.
13. Bailie, M., J. Standiford, L. Laichalk, M. Coffey, R. Strieter, and M. Peters-Golden. 1996. Leukotriene-deficient mice manifest enhanced lethality from klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J. Immunol. 157.5221-5224.
14. Coffey, M., S. Phare, P. Kazanjian, and M. Peters-Golden. 1996. Reduced 5-lipoxygenase metabolism in alveolar macrophages from subjects infected with the human immunodeficiency virus. J. Immunology. 157:393-399.
15. Lieschke, G., and A. Burgess. 1992. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N. Eng. J. Med. 327: 28.
16. Pouliot, M., P. McDonald, L. Khamzina, P. Borgeat, and S. McColl. 1994. Granulocyte-macrophage colony-stimulating factor enhances 5-lipoxygenase levels in human polymorphonuclear leukocytes. J. Immunol. 152:851-858.
17. Pouliot, M., P. McDonald, P. Borgeat, and S. McColl. 1994. Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils. J. Exp. Med. 179:1225-1232.
18. Sullivan, R., J. Griffin, E. Simons, A. Schafner, T. Meshulam, J. Fredette, A. Maas, A.-S. Gadenne, J. Leavitt, and D. Melnick. 1987. Effects of recombinant human granulocyte and macrophage colony-stimulating factors on signal transduction pathways in human granulocytes. J. Immunol. 139:3422-3430.
19. Mellors, J., L. Kingsley, C. Rinaldo, J. Todd, B. Hoo, R. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
20. Peters-Golden, M., R.W. McNish, R. Hyzy, C. Shelly, and G.B. Toews. 1990. Alterations in the pattern of arachidonate metabolism accompany rat macrophage differentiation in the lung. J. Immunol. 144:263-270.
21. Coffey, M., M. Peters-Golden, J. Fantone, and P. Sporn. 1992. Membrane association of active 5-lipoxygenase in resting cells: evidence for novel regulation of the enzyme in the rat alveolar macrophage. J. Biol. Chem. 267: 570-576.
22. Laemmli, U. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-685.
23. 2 to the nuclear fraction upon macrophage activation. Biochem. Biophys. Res. Commun. 196:18-24.
24. Chen, G., J. Curtis, C. Mody, P. Christensen, L. Armstrong, and G. Toews. 1994. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro. J. Immunol. 152:724-834.
25. Chuck, S., and M. Sande. 1989. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N. Eng. J. Med. 321:794-799.
26. Levitz, S. 1991. The ecology of cryptococcus neoformans and the epidemiology of cryptococcosis. Rev. Infect. Dis. 13:1163-1169.
27. Ring, W., C. Riddick, J. Baker, D. Munafo, and T. Bigby. 1996. Lymphocytes stimulate expression of 5-lipoxygenase and its activating protein in monocytes in vitro via granulocyte-macrophage colony-stimulating factor and interleukin 3. J. Clin. Invest. 97:1293-1301.
28. Watari, K., S. Asamo, N. Shirafuji, H. Kodo, K. Ozawa, F. Takakuet, and S. Kamachi. 1989. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood. 73:117-122.
29. 4 by human neutrophils in response to platelet-activating factor. J. Immunol. 146:1204-1211.
30. Denzlinger, C., A. Kapp, M. Grimberg, H. Gerhartz, and W. Wilmanns. 1990. Enhanced endogenous leukotriene biosynthesis in patients treated with granulocyte-macrophage colony-stimulating factor. Blood. 76:1765-1770.
31. Denzlinger, C., W. Tetzloff, H. Gerhartz, R. Pokorny, S. Sagebiel, C. Haberl, and W. Wilmanns. 1993. Differential activation of the endogenous leukotriene biosynthesis by two different preparations of granulocyte-macrophage colony-stimulating factor in healthy volunteers. Blood. 81:2007-2013.
32. Chaturvedi, V., B. Wong, and S. Newman. 1996. Oxidative killing of cryptococcus neoformans by human neutrophils. J. Immunol. 156:3836-3840.
33. Herbert, M.-J., T. Takano, H. Holthofer, and H. Brady. 1996. Sequential morphologic events during apoptosis of human neutrophils: modulation by lipoxygenase-derived eicosanoids. J. Immunol. 157:3105-3115.
34. 4) and superoxide from peripheral monocytes and neutrophils isolated from HIV infected individuals. Int. Conf. AIDS. 8:A60. (Abstr.)
35. Chang, K., H. Saito, I. Tatsuno, Y. Tamura, and S. Yoshida. 1991. Role of 5-lipoxygenase products of arachidonic acid in cell-to-cell interaction between macrophages and natural killer cells in rat spleen. J. Leukocyte Biol. 50: 273-278.
36. Skerrett, S., W. Henderson, and T. Martin. 1990. Alveolar macrophage function in rats with severe protein calorie malnutrition: arachidonic acid metabolism, cytokine release, and antimicrobial activity. J. Immunol. 144:1052-1061.
37. Bar-Shavit, Z., D. Noff, S. Edelstein, M. Meyer, S. Shibolet, and R. Goldman. 1981. 1,25-dihydroxyvitamin D3 and the regulation of macrophage function. Calcif. Tissue Int. 33:673-676.
38. Lu, M.-C., D. Hostetler, N. Robinson, F. Derksen, and M. Peters-Golden. 1995. Age-related increases in 5-lipoxygenase activity of cattle alveolar macrophages. Am. J. Physiol. 271:L547-L554.
39. Greco, N., M. Milks, and R. Panganamala. 1990. Metabolism of arachidonic acid in neutrophils from alloxan-diabetic rabbits. Prostaglandins Leukotrienes Essential Fatty Acids. 42:201-208.
40. Nelson, S., S. Farkas, N. Fotheringham, H. Ho, T. Marrie, and H. Movahhed. 1996. Filgrastim in the treatment of hospitalized patients with community acquired pneumonia. Am. J. Respir. Crit. Care. Med. 153S:A535. (Abstr.)